XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.2
STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance, beginning of period at Dec. 31, 2023   $ 48,057,158 $ (46,416,344) $ 1,640,814
Balance, beginning of period (in shares) at Dec. 31, 2023 [1] 679      
Increase (Decrease) in Stockholders' Equity (Deficit)        
Net loss     (3,326,812) (3,326,812)
Issuances of common stock, net $ 1 6,087,140   6,087,141
Issuances of common stock, net (in shares) [1] 5,607      
Share-based compensation   183,152   183,152
Balance, end of period at Mar. 31, 2024 $ 1 54,327,450 (49,743,156) 4,584,295
Balance, end of period (in shares) at Mar. 31, 2024 [1] 6,286      
Balance, beginning of period at Dec. 31, 2023   48,057,158 (46,416,344) 1,640,814
Balance, beginning of period (in shares) at Dec. 31, 2023 [1] 679      
Increase (Decrease) in Stockholders' Equity (Deficit)        
Net loss [1]       (8,517,626)
Balance, end of period at Jun. 30, 2024 $ 1 56,256,243 (54,933,970) 1,322,274
Balance, end of period (in shares) at Jun. 30, 2024 [1] 7,863      
Balance, beginning of period at Mar. 31, 2024 $ 1 54,327,450 (49,743,156) 4,584,295
Balance, beginning of period (in shares) at Mar. 31, 2024 [1] 6,286      
Increase (Decrease) in Stockholders' Equity (Deficit)        
Net loss     (5,190,814) (5,190,814) [1]
Issuances of common stock, net   785,198   785,198
Issuances of common stock, net (in shares) [1] 1,577      
Share-based compensation   1,143,595   1,143,595
Balance, end of period at Jun. 30, 2024 $ 1 56,256,243 (54,933,970) 1,322,274
Balance, end of period (in shares) at Jun. 30, 2024 [1] 7,863      
Balance, beginning of period at Dec. 31, 2024 $ 4 61,183,178 (63,201,916) (2,018,734)
Balance, beginning of period (in shares) at Dec. 31, 2024 [1] 36,753      
Increase (Decrease) in Stockholders' Equity (Deficit)        
Net loss     (12,085,413) (12,085,413)
Issuances of common stock, net $ 80 8,854,717   8,854,797
Issuances of common stock, net (in shares) [1] 796,930      
Exercise of Series D warrants   15,384,319   15,384,319
Share-based compensation   157,729   157,729
Balance, end of period at Mar. 31, 2025 $ 84 85,579,943 (75,287,329) 10,292,698
Balance, end of period (in shares) at Mar. 31, 2025 [1] 833,683      
Balance, beginning of period at Dec. 31, 2024 $ 4 61,183,178 (63,201,916) (2,018,734)
Balance, beginning of period (in shares) at Dec. 31, 2024 [1] 36,753      
Increase (Decrease) in Stockholders' Equity (Deficit)        
Net loss [1]       (16,361,915)
Balance, end of period at Jun. 30, 2025 $ 84 85,711,453 (79,563,831) 6,147,706
Balance, end of period (in shares) at Jun. 30, 2025 [1] 833,683      
Balance, beginning of period at Mar. 31, 2025 $ 84 85,579,943 (75,287,329) 10,292,698
Balance, beginning of period (in shares) at Mar. 31, 2025 [1] 833,683      
Increase (Decrease) in Stockholders' Equity (Deficit)        
Net loss     (4,276,502) (4,276,502) [1]
Share-based compensation   131,510   131,510
Balance, end of period at Jun. 30, 2025 $ 84 $ 85,711,453 $ (79,563,831) $ 6,147,706
Balance, end of period (in shares) at Jun. 30, 2025 [1] 833,683      
[1] On May 15, 2025, the Company effected a reverse split of the Company's common stock, either issued and outstanding or held by the Company as treasury stock. The May 2025 Reverse Split was at a ratio of one share for every 28 shares previously held with no change in the par value per share. The May 2025 Reverse Split did not change the number of authorized shares of common stock. All common stock share and per share data, and exercise price data for applicable common stock equivalents, included in these financial statements have been retroactively adjusted to reflect the Reverse Split.